Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Ovarian Neoplasms

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 39 articles: HTML format Text format

Single Articles

April 2010
1. LANGLAND GT , Yannone SM, Langland RA, Nakao A, et al
   Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities.
   Oncol Rep. 2010;23:1021-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. KUSUMOTO T , Kodama J, Seki N, Nakamura K, et al
   Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.
   Oncol Rep. 2010;23:917-25.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2010
3. LIU JJ , Lin B, Hao YY, Li FF, et al
   Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway.
   Oncol Rep. 2010;23:833-41.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. YOSHIHARA C , Hamada K, Koyama Y
   Preparation of a novel adenovirus formulation with artificial envelope of multilayer polymer-coatings: Therapeutic effect on metastatic ovarian cancer.
   Oncol Rep. 2010;23:733-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. ROOMI MW , Monterrey JC, Kalinovsky T, Rath M, et al
   In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
   Oncol Rep. 2010;23:605-14.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
6. KOLWIJCK E , Span PN, Thomas CM, Bulten J, et al
   Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.
   Oncol Rep. 2010;23:579-84.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
7. HEMMINGSSON O , Nojd M, Kao G, Naredi P, et al
   Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1.
   Oncol Rep. 2009;22:869-75.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. HUANG YW , Jansen RA, Fabbri E, Potter D, et al
   Identification of candidate epigenetic biomarkers for ovarian cancer detection.
   Oncol Rep. 2009;22:853-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
9. POLCHER M , Mahner S, Ortmann O, Hilfrich J, et al
   Neoadjuvant chemotherapy with carboplatin and docetaxel in advanced ovarian cancer - a prospective multicenter phase II trial (PRIMOVAR).
   Oncol Rep. 2009;22:605-13.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. YAO Q , Qu X, Yang Q, Wei M, et al
    CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer.
    Oncol Rep. 2009;22:541-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
11. ENGEL JB , Schonhals T, Weidler C, Hausler S, et al
    Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition.
    Oncol Rep. 2009;22:361-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. KOBAYASHI H , Kajiwara H, Kanayama S, Yamada Y, et al
    Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
    Oncol Rep. 2009;22:233-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
13. HEIN S , Mahner S, Kanowski C, Loning T, et al
    Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.
    Oncol Rep. 2009;22:177-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
14. LI J , Liu P, Mao H, Wanga A, et al
    Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
    Oncol Rep. 2009;21:1605-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
15. OKAMOTO S , Okamoto A, Nikaido T, Saito M, et al
    Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts.
    Oncol Rep. 2009;21:1209-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
16. HUA K , Din J, Cao Q, Feng W, et al
    Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway.
    Oncol Rep. 2009;21:893-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
17. BADIGLIAN FILHO L , Oshima CT, De Oliveira Lima F, De Oliveira Costa H, et al
    Canonical and noncanonical Wnt pathway: A comparison among normal ovary, benign ovarian tumor and ovarian cancer.
    Oncol Rep. 2009;21:313-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
18. SAITOU M , Isonishi S, Hamada T, Kiyokawa T, et al
    Mitochondrial ultrastructure-associated chemotherapy response in ovarian cancer.
    Oncol Rep. 2009;21:199-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
19. PAN W , Yang H, Cao C, Song X, et al
    AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells.
    Oncol Rep. 2008;20:1553-1559.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. REINHOLD U , Schmitz B, Kurbacher C, Nagel W, et al
    Circulating 25-hydroxyvitamin D concentration in German cancer patients.
    Oncol Rep. 2008;20:1539-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. ZHOU Y , Cheng Z, Zhu H, Feng D, et al
    Stable suppression of HER-2 gene expression using siRNA increases the lysis of human ovarian carcinoma cells mediated by NK-92 cell line.
    Oncol Rep. 2008;20:1425-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. NOSKE A , Lindenberg JL, Darb-Esfahani S, Weichert W, et al
    Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.
    Oncol Rep. 2008;20:1409-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. SAGA Y , Ohwada M, Suzuki M, Konno R, et al
    Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma.
    Oncol Rep. 2008;20:1299-303.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
24. YANG Y , Yang H, McNutt MA, Xiong F, et al
    LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
    Oncol Rep. 2008;20:1077-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
25. SHI J , Wan Y, Di W
    Effect of hypoxia and re-oxygenation on cell invasion and adhesion in human ovarian carcinoma cells.
    Oncol Rep. 2008;20:803-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
26. FUTYMA K , Putowski L, Cybulski M, Miotla P, et al
    The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples.
    Oncol Rep. 2008;20:683-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
27. HE Z , Gao J, Wang Q, Liu M, et al
    S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
    Oncol Rep. 2008;20:325-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
28. SONNEMANN J , Huls I, Sigler M, Palani CD, et al
    Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.
    Oncol Rep. 2008;20:219-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. TANAKA T , Toujima S, Utsunomiya T, Yukawa K, et al
    Experimental characterization of recurrent ovarian immature teratoma cells after optimal surgery.
    Oncol Rep. 2008;20:13-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
30. OBAYASHI Y , Yabushita H, Kanyama K, Noguchi M, et al
    Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer.
    Oncol Rep. 2008;19:1245-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. NAKAMURA K , Takamoto N, Hongo A, Kodama J, et al
    Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer.
    Oncol Rep. 2008;19:1085-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. TAKANO M , Sasaki N, Kita T, Kudoh K, et al
    Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging.
    Oncol Rep. 2008;19:1259-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. TANAKA T , Utsunomiya T, Utsunomiya H, Umesaki N, et al
    Irinotecan HCl, an anticancer topoisomerase I inhibitor, frequently induces ovarian failure in premenopausal and perimenopausal women.
    Oncol Rep. 2008;19:1123-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
34. LATTRICH C , Juhasz-Boess I, Ortmann O, Treeck O, et al
    Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
    Oncol Rep. 2008;19:811-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. HUAN Z , Nakayama K, Nakayama N, Ishibashi M, et al
    Genetic classification of ovarian carcinoma based on microsatellite analysis: relationship to clinicopathological features and patient survival.
    Oncol Rep. 2008;19:775-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. YAMAGUCHI K , Mandai M, Fukuhara K, Higuchi T, et al
    Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period.
    Oncol Rep. 2008;19:705-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
37. MATSUMURA N , Mandai M, Hamanishi J, Yamaguchi K, et al
    Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: Utilization for ovarian cancer treatment.
    Oncol Rep. 2008;19:505-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
38. BARBERA M , Caputo A, Zampiron A, Gobbi S, et al
    The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
    Oncol Rep. 2008;19:187-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. YASUDA M , Miyazawa M, Fujita M, Kajiwara H, et al
    Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character.
    Oncol Rep. 2008;19:111-6.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: